%0 Journal Article
%K Blood Pressure
%K Atherosclerosis
%K ACE inhibitors
%B Journal of the American College of Cardiology
%D 2000
%F journal
%G eng
%M 10933355
%P 438-43
%T Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. PART-2 Collaborative Research Group. Prevention of Atherosclerosis with Ramipril
%V 36
%! J. Am. Coll. Cardiol.